ENTITY

Revelation Biosciences (REVB US)

13
Analysis
Health Care • United States
Revelation Biosciences Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing therapeutics and diagnostics for viral infections by harnessing the power of the innate immune system. Revelation Biosciences serves customers worldwide.
more
•08 Nov 2025 01:00•Issuer-paid

REVB: 3Q Release Shows Company in Good Shape

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
•10 Sep 2025 01:00•Issuer-paid

REVB: Groundbreaking Test Results and Price Target Raise

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
•09 Aug 2025 00:00•Issuer-paid

REVB: Gemini Results to be Released Soon

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
•10 Jul 2025 00:00•Issuer-paid

REVB: Topline Results About to Be Released

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
•10 May 2025 03:00•Issuer-paid

REVB: New Market Potential and Quarterly Results

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Share
x